Auto-DC not checked
PT. Prodia Stem Cell Indonesia
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Treatment with Aqua Pro-Injection 2 cc, and then followed by Auto DC, interval 2 days (via Intramuscular)”In the company’s words, NCT05261750 on ClinicalTrials.gov
- Tested for
- Nasopharyngeal Cancer
- Main trialPhase 1/2
- “The purpose of this study is to determine the safety and potential of dendritic cells therapy and secretomes therapy for advanced nasopharyngeal cancer.”In the company’s words, NCT05261750 on ClinicalTrials.gov
Other drugs for Nasopharyngeal Cancer
- Izalontamab brengitecanSichuan Baili (Biokin, SystImmune) · Bristol Myers Squibb · Phase 3
- Tambotatug pelitecanMediLink Therapeutics (Suzhou) Co., Ltd. · Phase 3
- KL-A167Kelun-Biotech · Phase 3
- MRG003Lepu Biopharma Co., Ltd. · Phase 3
- PucotenlimabLepu Biopharma Co., Ltd. · Phase 3
- EnlonstobartCSPC · Phase 3
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Active, not recruiting | 28 Feb 2026 | Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026